Characterization of Antigenic MHC-Class-I-Restricted T Cell Epitopes in the Glycoprotein of Ebolavirus
Summary: Ebolavirus causes highly lethal hemorrhagic fever in humans. The envelope-displayed viral glycoprotein (GP) is the primary target of humoral immunity induced by natural exposure and vaccination. No T cell epitopes in the GP have been characterized in humans. A phase I clinical trial of a he...
Main Authors: | Jonathan Powlson, Daniel Wright, Antra Zeltina, Mark Giza, Morten Nielsen, Tommy Rampling, Navin Venkatrakaman, Thomas A. Bowden, Adrian V.S. Hill, Katie J. Ewer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-11-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221112471931438X |
Similar Items
-
Characterisation of antigenic MHC Class I-restricted T cell epitopes in the glycoprotein of Ebolavirus
by: Powlson, J, et al.
Published: (2019) -
<i>In Silico</i> Analyses, Experimental Verification and Application in DNA Vaccines of Ebolavirus GP-Derived pan-MHC-II-Restricted Epitopes
by: Junqi Zhang, et al.
Published: (2023-10-01) -
Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region.
by: Clara T Schoeder, et al.
Published: (2022-05-01) -
Glycan shield of the ebolavirus envelope glycoprotein GP
by: Weiwei Peng, et al.
Published: (2022-08-01) -
Activation-induced Markers Detect Vaccine-Specific CD4+ T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials
by: Georgina Bowyer, et al.
Published: (2018-07-01)